A detailed history of American Capital Advisory, LLC transactions in Organon & Co. stock. As of the latest transaction made, American Capital Advisory, LLC holds 2 shares of OGN stock, worth $29. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2
Previous 2 -0.0%
Holding current value
$29
Previous $29,000 34.48%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

SELL
$17.45 - $21.96 $1.38 Million - $1.74 Million
-79,144 Reduced 100.0%
2 $29,000
Q1 2024

Apr 29, 2024

BUY
$13.78 - $18.8 $1.09 Million - $1.49 Million
79,144 Added 3957200.0%
79,146 $1.86 Billion
Q4 2023

Apr 09, 2024

BUY
$10.95 - $17.32 $21 - $34
2 New
2 $29,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.75B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track American Capital Advisory, LLC Portfolio

Follow American Capital Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Capital Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on American Capital Advisory, LLC with notifications on news.